Treza12/datasetonePTBXL · Datasets at Hugging Face

subfolder stringclasses 22 values	prompt stringlengths 304 306	image imagewidth (px) 1k 1k
00000	ECG signal from 00000/00736_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00736_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00457_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00619_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00295_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00538_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00376_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00853_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00691_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.
00000	ECG signal from 00000/00934_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00736_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00457_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00619_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00295_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00538_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00376_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00853_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, V3, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, V4, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, V5, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00691_hr, V6, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, I, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, II, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, III, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, AVR, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, AVL, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, AVF, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, V1, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.

00000

ECG signal from 00000/00934_hr, V2, sampled at 500 Hz. The subjects include patients with myocardial infarctions, transient ischemia, ventricular tachyarrhythmias, and other risk factors for sudden cardiac death, as well as healthy controls and synthetic cases with calibrated amounts of T-wave alternans.